Literature DB >> 18628204

GABPbeta2 is dispensible for normal lymphocyte development but moderately affects B cell responses.

Xuefang Jing1, Dong-Mei Zhao, Thomas J Waldschmidt, Hai-Hui Xue.   

Abstract

GA-binding protein (GABP) is the only Ets family transcription factor that functions as a heterodimer. The GABPalpha subunit binds to DNA, and the GABPbeta subunit possesses the ability to transactivate target genes. Inactivation of GABPalpha caused embryonic lethality and defective lymphocyte development and immune responses. There are 3 isoforms of the GABPbeta subunit, but whether they have distinct functions has not been addressed. In this study, we selectively ablated the expression of GABPbeta2 using a gene trap strategy. GABPbeta2-deficient mice were viable and had normal T and B cell development, suggesting that loss of GABPbeta2 is compensated for by other GABPbeta isoforms during these processes. GABPbeta2-deficient T cells can be activated and proliferate similarly to wild-type controls. In contrast, B cells lacking GABPbeta2 showed 2-3-fold increases in proliferation in response to B cell receptor stimulation. In addition, GABPbeta2-deficient mice exhibited moderately increased antibody production and germinal center responses when challenged with T-dependent antigens. These results indicate that albeit GABPbeta isoforms are redundant in lymphocyte development, GABPbeta2 has a distinct role in restraining B cell expansion and humoral responses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18628204      PMCID: PMC3259847          DOI: 10.1074/jbc.M804487200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

Review 1.  The ETS-domain transcription factor family.

Authors:  A D Sharrocks
Journal:  Nat Rev Mol Cell Biol       Date:  2001-11       Impact factor: 94.444

2.  Regulation of E2F1-dependent gene transcription and apoptosis by the ETS-related transcription factor GABPgamma1.

Authors:  Ludger Hauck; Rudolf G Kaba; Martin Lipp; Rainer Dietz; Rüdiger von Harsdorf
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

Review 3.  Regulation of B-cell fate by antigen-receptor signals.

Authors:  Hiroaki Niiro; Edward A Clark
Journal:  Nat Rev Immunol       Date:  2002-12       Impact factor: 53.106

Review 4.  GA-binding protein transcription factor: a review of GABP as an integrator of intracellular signaling and protein-protein interactions.

Authors:  Alan G Rosmarin; Karen K Resendes; Zhongfa Yang; John N McMillan; Shawna L Fleming
Journal:  Blood Cells Mol Dis       Date:  2004 Jan-Feb       Impact factor: 3.039

5.  A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells.

Authors:  Nadia L Bernasconi; Nobuyuki Onai; Antonio Lanzavecchia
Journal:  Blood       Date:  2003-01-30       Impact factor: 22.113

Review 6.  Toll-like receptor control of the adaptive immune responses.

Authors:  Akiko Iwasaki; Ruslan Medzhitov
Journal:  Nat Immunol       Date:  2004-10       Impact factor: 25.606

7.  The ETS transcription factor GABPalpha is essential for early embryogenesis.

Authors:  Sika Ristevski; Debra A O'Leary; Anders P Thornell; Michael J Owen; Ismail Kola; Paul J Hertzog
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

8.  Convergence of Ets- and notch-related structural motifs in a heteromeric DNA binding complex.

Authors:  C C Thompson; T A Brown; S L McKnight
Journal:  Science       Date:  1991-08-16       Impact factor: 47.728

9.  GA binding protein regulates interleukin 7 receptor alpha-chain gene expression in T cells.

Authors:  Hai-Hui Xue; Julie Bollenbacher; Valentina Rovella; Radhika Tripuraneni; Yu-Bin Du; Cheng-Yu Liu; Ann Williams; J Philip McCoy; Warren J Leonard
Journal:  Nat Immunol       Date:  2004-09-07       Impact factor: 25.606

Review 10.  Toll-like receptors.

Authors:  Kiyoshi Takeda; Tsuneyasu Kaisho; Shizuo Akira
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

View more
  5 in total

1.  GABP controls a critical transcription regulatory module that is essential for maintenance and differentiation of hematopoietic stem/progenitor cells.

Authors:  Shuyang Yu; Kairong Cui; Raja Jothi; Dong-Mei Zhao; Xuefang Jing; Keji Zhao; Hai-Hui Xue
Journal:  Blood       Date:  2010-12-07       Impact factor: 22.113

2.  TLR3- and MyD88-dependent signaling differentially influences the development of West Nile virus-specific B cell responses in mice following immunization with RepliVAX WN, a single-cycle flavivirus vaccine candidate.

Authors:  Jingya Xia; Evandro R Winkelmann; Summer R Gorder; Peter W Mason; Gregg N Milligan
Journal:  J Virol       Date:  2013-08-28       Impact factor: 5.103

3.  Targeting tetramer-forming GABPβ isoforms impairs self-renewal of hematopoietic and leukemic stem cells.

Authors:  Shuyang Yu; Xuefang Jing; John D Colgan; Dong-Mei Zhao; Hai-Hui Xue
Journal:  Cell Stem Cell       Date:  2012-08-03       Impact factor: 24.633

4.  Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner.

Authors:  Andrew Mancini; Ana Xavier-Magalhães; Wendy S Woods; Kien-Thiet Nguyen; Alexandra M Amen; Josie L Hayes; Christof Fellmann; Michael Gapinske; Andrew M McKinney; Chibo Hong; Lindsey E Jones; Kyle M Walsh; Robert J A Bell; Jennifer A Doudna; Bruno M Costa; Jun S Song; Pablo Perez-Pinera; Joseph F Costello
Journal:  Cancer Cell       Date:  2018-09-10       Impact factor: 31.743

5.  The transcription factor Runx3 guards cytotoxic CD8+ effector T cells against deviation towards follicular helper T cell lineage.

Authors:  Qiang Shan; Zhouhao Zeng; Shaojun Xing; Fengyin Li; Stacey M Hartwig; Jodi A Gullicksrud; Samarchith P Kurup; Natalija Van Braeckel-Budimir; Yao Su; Matthew D Martin; Steven M Varga; Ichiro Taniuchi; John T Harty; Weiqun Peng; Vladimir P Badovinac; Hai-Hui Xue
Journal:  Nat Immunol       Date:  2017-06-12       Impact factor: 25.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.